Starpharma Institutionelles Eigentum
Was ist das Institutionelles Eigentum von Starpharma?
Institutionelles Eigentum von Starpharma Holdings Limited ist 42.81%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Health Care Sektor auf ASX im Vergleich zu Starpharma
Was macht Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Unternehmen mit institutionelles eigentum ähnlich Starpharma
- T-Mobile US hat Institutionelles Eigentum von 42.78%
- Rubis SCA hat Institutionelles Eigentum von 42.78%
- Orora hat Institutionelles Eigentum von 42.79%
- Sculptor Capital Management hat Institutionelles Eigentum von 42.79%
- Sculptor Capital Management hat Institutionelles Eigentum von 42.79%
- The Great Eastern Shipping hat Institutionelles Eigentum von 42.80%
- Starpharma hat Institutionelles Eigentum von 42.81%
- Dish TV India hat Institutionelles Eigentum von 42.82%
- Middlefield Canadian Income PCC hat Institutionelles Eigentum von 42.83%
- Fuelcell Inc hat Institutionelles Eigentum von 42.84%
- Grupo Televisa SAB hat Institutionelles Eigentum von 42.84%
- UniCredit SpA hat Institutionelles Eigentum von 42.85%
- W & T Offshore Inc hat Institutionelles Eigentum von 42.85%